Executive members’ profile

Professor Tom Robinson
President, British Association of Stroke Physicians (2018 to 2019)


I am Head of the Department of Cardiovascular Sciences and Professor of Stroke Medicine at the University of Leicester, and Honorary Consultant Physician in Stroke Medicine at the University Hospitals of Leicester NHS Trust. OI lead the Cerebral Haemodynamics in Ageing and Stroke Medicine (CHiASM) Research Group at the University of Leicester, and my research interests relate to the study of cerebral haemodynamics and in particular the impact of changes in cerebral haemodynamic control mechanisms on the management of blood pressure, blood pressure variability and other physiological parameters following acute stroke through undertaking randomized controlled trials and other well-designed studies. In addition to research and clinical practice, I am the current President of the British Association of Stroke Physicians (2018 to 2019), and the National Specialty Lead for Stroke for the National Institute for Health Clinical Research Network (2015 to date).

Stroke and Me

I undertook my training in General Internal and Geriatric Medicine in Nottingham, Newcastle-Upon-Tyne and Leicester. My initial interest in Stroke Medicine was piqued as a Stroke Association Clinical Research Fellow with Professor John Potter between 1993 and 1995, when I first studied the cardiovascular and cerebral haemodynamic consequences of acute stroke, culminating in the award of an MD from the University of Leicester. I was subsequently first appointed as a Consultant Physician and Stroke Association District Stroke Co-ordinator in Leicester in 1997, and ‘given’ 6 beds on Professor Mark Castleden’s ward at the Leicester General Hospital with which to start a stroke service. This quickly expanded to the whole ward, and over the years to a HASU and two acute wards at the Leicester Emergency site, with three rehabilitation wards each at three other hospital sites, an early supported discharge service, a one-stop TIA service, and a ‘drip and ship’ service for mechanical thrombectomy with Nottingham; this massive expansion led by my colleagues who it has been and is my privilege to work with.

My initial period as an NHS consultant lasted three years before an opportunity arose to return to academia in 2000 as John Potter’s Senior Lecturer, which led to the development of my interest in clinical trials, especially in acute blood pressure management with CHHIPS and COSSACS, as well as being able to continue primary research in cardiovascular and cerebrovascular regulation in acute stroke.  I was fortunate to be there at the start of the NIHR Stroke Research Network in 2006, led by Professor Gary Ford, as the Trent Local Stroke Research Network Lead, which provided the opportunities for international collaboration and my partnership with Professor Craig Anderson in ENCHANTED, HeadPoST and INTERACT, with more trials in the pipeline!

As well as developments in the Research Network, there was also opportunity within a vibrant Clinical Network led by Professor Tony Rudd and Damian Jenkinson, which allowed me to work with many multi-disciplinary colleagues in the East Midlands in the development and reorganisation of our hospital and community stroke services during the 2010s. This period of my career was also when I had the privilege to Chair the Stroke Medicine Specialty Advisory Committee and become involved in the stroke training agenda, as well as beginning my Executive roles with BASP in the Scientific Committee and now Presidency.

So Stroke and me – it has provided an opportunity to work in research, in teaching and training, in clinical management, but above all in everyday clinical practice with patients and their families across the entire stroke pathway; though my colleagues would say that I now do much less of the latter! A professionally satisfying, intellectually stimulating career with abundant and ample opportunity – why look for a career in any other specialty?

Professor Rustam Al-Shahi Salman
President Elect, British Association of Stroke Physicians (2018 to 2019)

Professor Rustam Al-Shahi Salman MA MB BChir PhD FRCP Edin FHEA FESO.
I am a professor of clinical neurology at the University of Edinburgh and honorary consultant neurologist in NHS Lothian (professional webpage). I lead the Research to Understand Stroke due to Haemorrhage (RUSH) programme (, which is dedicated to improving the outcome for adults who have diseases that may cause, or have caused, intracranial haemorrhage. I also care for people with these conditions, audit their care, and help undergraduate and postgraduate students to develop and answer research questions within the RUSH programme. I am committed to BASP’s vision to provide leadership in the improvement of clinical services, science and research, education and training relating to the health and wellbeing of our patients, their carers and the public. I look forward to leading the delivery of the current BASP strategy and updating it for the following three years as BASP president 2020-2021.

Stroke and Me

I became interested in neurology during undergraduate medical training at Cambridge University. The importance of stroke as a common neurological disease became apparent to me while I was a house officer working with Nick Coni in Cambridge in 1994. Concerned by the shortage of treatments for stroke, I was inspired by the clinical research that was being done to address this whilst I was a senior house officer at the Whittington Hospital in London 1994-1996. During this time, recruiting patients to the first International Stroke Trial gave me first-hand experience of how large, simple randomised trials could answer uncertainties about treatments reliably and easily. Attending the Edinburgh Clinical Trials course helped me to understand how to do this, and attending Charles Warlow’s Advanced Clinical Neurology Course in Edinburgh confirmed my commitment to advancing stroke care, even though this has not been the cultural norm for neurologists in the UK.

In order to realise these ambitions, I wrote funding applications in the small hours of the morning whilst I was a trainee doctor in London for funding from the Chief Scientist Office to set up a population-based cohort study in Scotland and funding from the MRC for a clinical research training fellowship to allow me to conduct a PhD. These grants enabled me to move to Edinburgh and join the stroke research group in 1998.

Subsequently, I undertook clinical training to be a neurologist in Edinburgh and kept my research going alongside a full-time training post. I progressed to MRC patient-oriented clinician scientist and senior clinical fellowships until 2016. Since becoming a professor of clinical neurology at the University of Edinburgh in August 2013, the depth and breadth of my research has expanded beyond stroke and intracranial haemorrhage in response to several of the global challenges in non-communicable diseases, vascular multi-morbidity, cerebral small vessel diseases, and therapeutic dilemmas provoked by vascular ageing (

My lived experience of clinical research has also made me concerned about increasing the value of biomedical research by minimising waste in the choice of research question, study design, study conduct, regulation, and reporting.  This led to me becoming one of the lead authors of The Lancet‘s 2014 Series on Increasing Value and Reducing Waste in Research ( and the related campaign (, as well as a founding member of the REWARD Alliance (

My clinical work in stroke includes TIA/stroke clinics, a specialist service for people with intracerebral haemorrhage or conditions that may cause it, out-of-hours thrombolysis on call work, and emergency stroke outreach services to my hospital’s emergency department and inpatient wards. My involvement with these services has made me acutely aware of the large shortfall (33%) in the clinical capacity at consultant and trainee level that we have to deliver the astounding advances in stroke care that have been discovered by clinical research in recent years.

For all of these reasons, I sought election to serve BASP as the specialty’s professional organization in order to continue the UK’s great tradition of clinical stroke research (BASP scientific committee member 2011-2014 and chair 2014-2017) and redress the balance in the clinical services that the NHS allows us to provide for patients with stroke in the UK (BASP president elect 2018-2019 and president 2020-2021).

Professor Helen Rodgers MBChB, FRCP
Past President, British Association of Stroke Physicians (2017 to 2019)

I am Professor of Stroke Care at Newcastle University and hold honorary stroke consultant posts with Northumbria Healthcare NHS Foundation Trust and Newcastle upon Tyne Hospitals NHS Foundation Trust. I undertook undergraduate and post graduate training in Leeds before returning to my native Newcastle to undertake a Wellcome Training Fellowship in Clinical Epidemiology. My research focusses upon development and evaluation of stroke services and rehabilitation. I have held a number of posts within BASP: scientific committee member (1998-200); chair Health Policy and Service Development Committee (now the Clinical Standard Committee (2000-2005)); and BASP president (2015 – 2017). I currently chair the Joint Stroke Medicine Committee of the Royal College of Physicians (London) and I am chair of the Stroke Rehabilitation and Ongoing Care Working Group for the NHS England Long Term Plan.

Stroke and Me

I have seen enormous improvement in the quality care of stroke patients over the course of my career and the speciality continues to evolve. When I qualified in 1983, there was a debate about whether or not stroke patients should be admitted to hospital. For those who were admitted, there was a huge variation in the quality of care and at times a nihilistic attitude to their care. Indeed a BMJ editorial stated that stroke patients were regarded as boring and bed blocking and challenged the profession to improve their care.

I really enjoyed my SHO post in geriatric medicine at St James’s Hospital in Leeds where I learnt a great deal about patient-centred care. I decided to pursue a career in geriatric medicine/neurology with an interest in stroke. I then spent three years as a research registrar within neurology at the Royal Victoria Infirmary, Newcastle. In 1993 I was appointed to the newly established post of Senior Lecturer in Stroke Medicine and Services at Newcastle University which enabled me to combine my interests in research, clinical practice and service development. I undertook one of the first RCTs of early supported discharge services, and with colleagues established the TIA clinic in Newcastle.  I really enjoy taking a clinical history and find TIA clinic very rewarding. It is great to be able to offer rapid access to a specialist service with same day investigations and secondary prevention.

In 1997 I became an honorary stroke consultant at Northumbria Healthcare NHS Foundation Trust Trust where I contribute to the acute stroke rota. I previously also contributed to running one of our stroke rehabilitation units. Looking after stroke patients throughout their in-patient stay was important to me and I thoroughly enjoyed working with a skilled enthusiastic multidisciplinary team.

Until 2015, our Trust had three acute hospitals and weekends on call consisted of daily trips to all three hospitals supported by telemedicine. It took me a while to get used to telemedicine and for the first few years I would make the decision to thrombolyse at home and asked for tPA to be given. I then drove to the hospital to check that I’d made the right decision. Since 2015 all hyperacute stroke care has been provided in a brand new hospital, Northumbria Specialist Emergency Care Hospital. We have 11 HASU beds and stroke consultants are on call on site 8am until 8pm and then by telemedicine until the following morning. I enjoy seeing patients in A&E and on the stroke unit, and the radiology service is amazing with rapid access to CT, MRI and Doppler. We have a drip and ship model with Newcastle for thrombectomy, and Northumbria colleagues contribute to the Newcastle stroke physicians rota.

I’ve always been keen to support national initiatives and I have been a member of the Intercollegiate Stroke Working Party since 2002 and I was associate director for patient and carer involvement with the Stroke Research Network 2005-2015.  Being involved with BASP and national stroke initiates has enabled me to contribute to improving services and has helped both my personal clinical practice and our local services.

Throughout my career the stroke community has been very supportive and works well together. There is a sense of ‘us’ as we work to improve patient care. For me, the most important aspect of my post is working with inspirational and supportive colleagues towards common goals. I will be retiring shortly and my colleagues in Northumbria, Newcastle, BASP, Stroke Research Network, ICSWP, Newcastle University and research collaborators are a joy to work with. If I were starting again would I choose a career in stroke medicine? – most definitely yes.

David Werring
Secretary, BASP

I am a professor of clinical neurology and honorary consultant neurologist at the Stroke Research Centre, UCL Institute of Neurology, Queen Square, and the National Hospital for Neurology and Neurosurgery (NHNN), University College Hospitals (UCH) NHS Foundation Trust. I contribute to delivering hyperacute and acute stroke care, and run a specialist clinical service and research program in intracerebral haemorrhage and cerebral small vessel disease. My projects include randomised controlled clinical trials and observational (clinical and neuroimaging) studies of cardioembolic stroke, cerebral microbleeds, intracerebral haemorrhage, subarachnoid haemorrhage, and cerebral amyloid angiopathy. I am Chief Investigator of the BHF-funded OPTIMAS (OPtimal TIMing of Anticoagulation after Stroke) trial investigating early oral anticoagulation in ischaemic stroke associated with atrial fibrillation; and of the Stroke Association-funded PROHIBIT-ICH (PRevention Of Hypertensive Injury to the Brain by Intensive Treatment in IntraCerebral Haemorrhage). I am head of the research department of Brain Repair and Rehabilitation at the UCL Queen Square Institute of Neurology. I am chair of the Association of British Neurologists Stroke Advisory Group, Stroke Specialty Lead for the NIHR North Thames Clinical Research Network, member of the board of directors of the European Stroke Organisation, recent member of the National Institute for Health and Care Excellence (NICE) Stroke Guideline Committee, and member of the Editorial Boards of the European Journal of Stroke and Practical Neurology. I am Chair-Elect of the UK Stroke Forum, the largest multidisciplinary stroke conference in the UK.


Stroke and me

My interest in stroke began as a junior house officer in the early 1990s. I noticed that people with heart attacks were treated urgently and transferred to the coronary care unit for specific treatment, while people with stroke were admitted to general medical wards and had no specific interventions. If they had a brain scan it was often delayed for many days. There was a feeling that stroke was not a treatable disease, and not much optimism about prospects for treatment – although I do remember helping recruit patients to the International Stroke Trial of acute antithrombotic therapy. I felt that things needed to improve and had an idea that I might one day specialise in stroke.

I began my training in neurology in the mid-1990s at Queen Square, but at this time there was very little interest in stroke, which was not really considered a neurological disease. On the advice of trusted mentors (David Marsden, Alan Thompson, Ian MacDonald) I did a PhD in brain imaging, mainly in multiple sclerosis, using advanced MRI scans including diffusion weighted sequences. Around this time, in the late 1990s it became clear that diffusion-weighted MR imaging was an extraordinarily powerful diagnostic test for acute stroke, and could also reveal in exquisite detail the consequences of injury to the smallest blood vessels in the brain (both ischaemic and haemorrhagic tissue damage).

It was also around this time (early 2000s) that stroke was being established as a separate specialty, and evidence had begun to emerge about successful acute treatment including intravenous thrombolysis. I decided that this was a great time to go into the specialty of stroke medicine and, thanks to a Stroke Association clinical fellowship, I was able to spend a year learning about the care of stroke patients and undertaking some research. Using some of the skills I had developed in my PhD studies, I was able to do some of the first studies looking at cerebral microbleeds and their influence on cognitive function and bleeding risk. I was hooked on the idea of trying to be a clinical academic in stroke neurology.

I was lucky to be able to include some stroke specialty work in my first consultant (general) neurologist post at Watford and Queen Square, though initially much of my work was in the care of inpatients and outpatients with general neurological problems. Alongside this busy clinical work, which I very much enjoyed, I continued to develop my interest in cerebral small vessel disease, with particular emphasis on bleeding in the brain and how to understand and prevent it. Just as my research was getting really interesting the Department of Health funded the “new blood” Senior Clinical Lectureships which, together with a Stroke Association project grant, and support from mentors including Martin Brown, gave me the opportunity to work as a clinical academic in stroke at Queen Square, and begin to build an independent research team. I became particularly interested in cerebral amyloid angiopathy, a common cause of brain haemorrhage and dementia that at the time was not really on the radar for most neurologists or stroke physicians.

I feel privileged to have had the opportunity to contribute to such a rapidly developing a and exciting specialty. In particular it has been very satisfying to be involved in developing a new hyperacute stroke unit at University College hospital, and to see the increased interest in small vessel disease including the treatment of and prevention of intracerebral haemorrhage. And in the last few years the advent of mechanical thrombectomy has transformed the care of people with the most severe ischaemic strokes.

Although clinical stroke work can be demanding and intensive, the variety and interest is extraordinary, as is the satisfaction of seeing many stroke patients improve and recover. In parallel, academic stoke research has provided an opportunity to work with many talented researchers from all over the UK and the world. I have been lucky to be able to develop many friendships and collaborations. It has been especially exciting to see the growth of the NIHR research network which has allowed many researchers in the UK to undertake collaborative research at many sites on a scale that would have been almost unimaginable in the past.

I have been involved in BASP for many years (initially on the Scientific Committee) and have enjoyed seeing the organisation develop under several inspiring Presidents.  I am looking forward as Secretary to helping our team to deliver the BASP strategy and serving the brilliant UK stroke clinical and research community.

I lead a stroke research team at the UCL Stroke Research Centre, and am always interested to hear from young clinicians or budding researchers who would like to work in this field with our team.


Twitter: @UCLStrokeRes



Fergus Dougal
BASP Clinical Standards Committee Chair

Fergus is a stroke physician based in Edinburgh, UK with research interests in to cerebral small vessel disease and patient centred projects.  He is committed to improving patient care and standards with equity of access a key proponent of his work.  Please get in touch with any suggestions or comments about how BASP might be able to help.

William Whiteley
BASP Scientific Committee Chair

William Whiteley is a Scottish Senior Clinical Fellow (funded by CSO) in the Centre for Clinical Brain Sciences, University of Edinburgh.

He is also Senior Clinical Fellow in the Nuffield Department of Population Health, University of Oxford; an International Fellow at the Population Health Research Institute, University of McMaster (Canada); and a consultant neurologist in NHS Lothian, working with patients with TIA, stroke and dementia.

His work seeks to elucidate the mechanisms for prevention of disability due to stroke and dementia through the design, delivery and analysis of epidemiological studies and clinical trials. Of particular interest are: the contribution of vascular risk factors to dementia; the very long term follow-up of randomized trials; clinical diagnosis; and the better use of large electronic health record datasets for more efficient clinical trials and cohort studies.

He has founded and run the Edinburgh Stroke Winter School and the Princess Margaret Research Development program which supported 5 clinicians to independent fellowship funding. He has been supported by personal fellowships from the UK MRC (Clinician Scientist fellowship 2010-2015), the Chief Scientist’s Office (2006-2009, 2018-2025), and his work by the Alzheimer’s Society, the Stroke Association and Chest, Heart and Stroke Scotland.


Current Research Interests

  • Contribution of known vascular risk factors to dementia
  • Diagnosis and treatment of minor and transient neurological attacks
  • Development of novel methods for large scale trials with electronic health records

Iain McGurgan
BASP Trainee Committee Chair

Ian is a Clinical Research Fellow in Neurovascular Disease at the University of Oxford, with an interest in diagnosing and managing high blood pressure to reduce stroke risk. He is heavily involved in medical student teaching, holding clinical tutor positions in three Oxford colleges and authoring a number of medical textbooks, and is committed to improving stroke education. A priority of his is the implementation of a stroke education programme for medical schools in the UK, and other initiatives to engage potential future stroke physicians to address our workforce crisis.

Dr Terry Quinn
BASP Ordinary Member Representing Scotland

Dr Terry Quinn FESO, FRCP, MD, MBChB (hons), BSc (hons)

I am a Senior Clinical Lecturer and Honorary Consultant Physician based in the Institute of Cardiovascular and Medical Sciences, University of Glasgow.

As a researcher I have a broad portfolio. My interests include research methodology, functional/cognitive assessment and frailty. My major research projects at the moment are around the psychological consequences of stroke.  I am growing a research group in this previously neglected area and I supervise an enthusiastic group of likeminded researchers.

I (try to) combine my research and policy work with teaching and clinical commitments in the stroke wards of Glasgow Royal Infirmary.

My role in BASP is as Ordinary Member for Scotland.  My remit is to represent the Scottish stroke workforce and keep BASP informed of stroke developments North of the Border.  This role is nicely aligned with my seat on the Scottish Parliament Heart and Stroke Disease Cross-Party Group and my work with Healthcare Improvement Scotland.  Scotland has a proud history in advancing stroke care and I am not afraid to promote and protect this.

I have a passion for ensuring that research is designed, conducted and reported well.  To this end I hold various editorial board positions, including coordinating editor of the Cochrane Dementia Group (, core member of the NIHR Complex Reviews Support Group ( and chair of OPSYRIS, the stroke psychology special interest group of the World Federation of Neuropsychology (

Stroke and Me 

I studied Medicine at University of Glasgow and from early in my student days I had excellent teaching on stroke, from International leaders in stroke research.  I also had a very enjoyable elective period working with the stroke team in Melbourne, but my ambitions were to become a psychiatrist.

Time spent studying in the Institute of Psychiatry, London and my first junior doctor jobs in Glasgow with the Institute of Neurological Sciences and the Western Infirmary, Professorial Medical Unit all shaped the young Dr. Quinn.  I realized that my dream job would combine the best bits of psychiatry, neurology and general medicine.

I wasn’t sure if such a job existed and so I decided to take some time out of the NHS to do research.  I approached Professor Kennedy Lees in Glasgow and started working on a project looking at measuring stroke recovery.  Without realizing it, I had discovered the dream job – stroke medicine includes aspects of all the things I was interested in.  It is incredibly satisfying to work with someone from the first days of their stroke through to recovery and return home.

I continued my research with Professor Lees and his team, but for clinical work I moved to the North of the city to take up a Registrar and Lectureship post in the Department of Geriatric Medicine.  Working with Professor David Stott, Professor Peter Langhorne and others, I began to develop my own research projects.  My interest in psychiatry never left and my research increasingly explored the psychological consequences of stroke.  With funding support from the Royal College of Physicians and Surgeons Glasgow, I spent some time learning about older adult psychiatry in Oxford.  This was great clinical experience but also began a fruitful relationship with the Cochrane Dementia Group.

I wasn’t the only person to recognise a need for more research in stroke psychology.  At just the right time for me, The Stroke Association announced a call for research around vascular dementia and stroke psychology.  I was fortunate enough to receive the first joint Stroke Association and Chief Scientist Office Senior Clinical Lectureship and their first Priority Program Grant.  This support was transformative and allowed me to start building my own research group.  I continue my research in stroke, dementia and other psychological problems.  It is heartening to see the progress made in this field, but there is still a lot to do.

The University of Glasgow have always been very supportive of my work and I wanted to give something back. So, I have taken on a number of supportive roles including, vice chair of the ethics committee, advisor of studies for undergraduate medical students and Athena Swan Self-Assessment Team.  More recently, I have started leading the Glasgow Academic Training Environment (GATE) and look forward to supporting and mentoring the next generation of clinical academics.

I firmly believe that research should not be reserved for academics.  To improve the visibility and accessibility of stroke research for patient, carers and lay public, I lead the Scottish Stroke Research Network public engagement group.  We have initiated a number of schemes around research dissemination and involvement and were recently awarded a prize from University of Glasgow for this work.  I am always happy to hear from people with lived experience of stroke, who wish to share their knowledge to help improve stroke research.


Twitter: @DrTerryQuinn


Dr Tom Hughes
BASP Ordinary Member Representing Wales

Dr Tom Hughes MBBS FRCP MD, President, Welsh Association of Stroke Physicians (WASP)Council Member, BASP

I am a Consultant Neurologist and Clinical Director of Medical Neurosciences in the University Hospital of Wales, Cardiff.  I also chair the Specialist Advisory Committee (SAC) for Neurology in the Joint Royal College of Physicians Training Board (JRCPTB) in which role I have led – for Neurology –  the negotiations and planning involved in the Shape of Training reforms, the first trainees in which started their Internal Medicine in August 2019.

As a junior doctor I remember well being the person pushing the notes trolley past the patients who had been labelled “ordinary stroke” – by which my consultant meant it was not a result of infective endocarditis or an atrial myxoma – even though the underlying pathologies were susceptible to rational explanation and secondary preventative strategies, and their disabilities were profound and life changing.  This therapeutic nihilism has now been superseded by exciting developments in treatment and understanding.  The pace of change, the beneficial – and detrimental – effect of the interventions, and the repertoire of skills required to be a good stroke physician, makes the subject of stroke medicine exciting and very worthwhile.  For these reasons, and to promote closer cooperation between stroke medicine and neurosciences – locally and nationally – I resigned from my neurology post in 2017 to work full time as an acute stroke physician.

Trials of treatment have been an important part of my engagement in stroke, as a PI, starting with the IST3 trial, then RESTART, and now SOSTART.  Clinical trials allow uncertainties to be shared and help NHS clinicians maintain their engagement with important research. The subject of my MD thesis with Professor Mark Wiles in Cardiff was the measurement of swallowing in health and in motor neurone disease which informs directly my approach to the assessment and management of the disability we see in stroke patients.

I am pleased to be on the executive of BASP to try and contribute to the raising of standards of stroke medicine in the UK.


Dr Indira Natarajan
BASP Ordinary Member Representing England

I am currently  Clinical director of Neurosciences at University Hospital of North Midlands and Honorary Senior Lecturer Keele University. . I am also the Clinical Director for Stroke for the West Midlands Strategic Health Network.

Following my qualification in 1992, I did my postgraduate training in Medicine in South Manchester, North Wales and Exeter.   My Specialist Training was in the West Midlands during which time I developed a Special Interest in Stroke Medicine. I did my Stroke Fellowship year at St. Mary’s Hospital London. I worked as a Specialist Registrar for 3 years at the University Hospital North Midlands and having enjoyed every bit of my time here I returned back to the Potteries as a Consultant Stroke Physician.

Since my appointment here at UHNM I lead the Implementation of the Regional thrombolysis rota across Shropshire and Staffordshire.

I have been Championing Stroke prevention secondary to atrial fibrillation to the wider community with key aim of preventing disabling strokes. Established this unique service which was nurse led intervention and this work was recognised with the Royal College of Physicians innovation in Patient Care Award for our work on Stroke Prevention in Atrial Fibrillation 2016

I lead the Implementation of Neuro-interventional pathway for Hyper-acute strokes for clinical and research purposes at University Hospital of North Midlands and the wider West Midlands region in my role as the Regional Clinical Director for Stroke.

Stroke and Me:

When I was a trainee doctor at Royal Stoke Hospital I got inspired in a career in Stroke Medicine  from Prof. Roffe who was my mentor.  My clinical work in stroke includes TIA/stroke clinics, a specialist service for people with cardioembolic strokes  or conditions that may cause it, out-of-hours thrombolysis on call work, and emergency stroke outreach services to my hospital’s emergency department and also to support the local hospitals needing expert stroke advice across the West Midlands.



    Prof. Tom Robinson

    Past President

    Prof. Helen Rodgers

    President Elect

    Prof. Rustam Salman


    Prof. David Werring

    Deputy Secretary

    Dr. Ganesh Subramanian

    Chair Clinical Standards Committee

    Dr. Fergus Doubal

    Chair Training & Education Committee

    Dr. Declan O'Kane

    Chair Scientific Committee

    Dr Will Whiteley

    Hon Treasurer

    Dr. Richard Curless

    Chair Trainees Comittee

    Dr. Iain McGurgan

    Member (England)

    Dr Deborah Lowe

    Member (England)

    Dr. Indira Natarajan

    Member (Scotland)

    Dr. Terry Quinn

    Member (NI)

    Dr. Michael McCormick

    Member (Wales)

    Dr. Tom Hughes


    Mrs Trish O'Neill

    Member without portfolio

    Prof. Martin James



    Dr Will Whiteley


    Dr Phil Clatworthy


    Dr. Tim England


    Dr. Liz Warburton


    Dr. Adrian Parry-Jones


    Dr Jon Hewitt


    Dr Mary Joan Macleod

    Trainee Member

    Dr Nicholas Evans



    Dr. Fergus Doubal


    Dr. Indira Natarajan


    Dr. Ivan Wiggam


    Dr. Sree Andole


    Dr. Anand Dixit


    Trainee Member

    Dr. Jason Appleton

    Member (Co-opted)

    Dr. Michelle Dharmasiri

    Member (Co-opted)

    Dr. Simon Hart

    Member (Co-opted)

    Dr. Alexis Kolodziej (SA_

    Member (Co-opted)

    Dominic Brand (SA)

Trainees Committee 2019


    Dr. Iain McGurgan

    Deputy Chair

    Dr. Nick Evans

    Member ABN Rep

    Dr. Samuel Shribman



    Dr. Rob Hurford


    Dr. Chris Wharton

    Member CSC rep

    Dr. Jason Appleton


    Dr. Daniel Burrage




    Dr. Isuru Induruwa

Training & Education Committee 2019


    Dr. Declan O'Kane


    Dr. Sunil Munshi


    Dr. Kirsty Harkness


    Dr. Louise Shaw


    Dr Kailash Krishnan

    Trainee Member

    Dr Chris Wharton

    Trainee Member

    Dr. Rob Hurford

    Member (Co-opted)

    Dr Anthony Pereira

    Member (Co-opted)

    Dr David Hargroves

    Member (Co-opted)

    Dr. Jon Cooper

Patients & Carers

If you are a patient or carer seeking advice about stroke, please visit our patients and carers page. MORE INFORMATION


Stay up to date with the latest news and community papers published by BASP. READ MORE


Find out what events/conferences are taking place in and around your area regarding your fields of interest. READ MORE

Become a Member

Would you like to join us? The British Association of Stroke Physicians are advancing stroke medicine and helping to promote better care for people with stroke in the UK. READ MORE